Bone formation in rabbit cancellous bone defects filled with bioactive glass granules

Bone healing in cancellous defects remains a clinical challenge. Prior research has shown that autogenous bone grafts are effective but limited by donor site morbidity. This gap motivated investigations into alternative grafting materials. Bioactive glass has been proposed as a potential substitute due to its osteoconductive properties. However, the exact mechanism of new bone formation with bioactive glass granules is not fully understood. This uncertainty drove the need for comparative studies with established grafting methods. No prior work had resolved the long-term integration of bioactive glass in cancellous bone defects. The study aimed to clarify how bioactive glass granules interact with bone tissue over time.

The aim was to evaluate new bone formation in cancellous bone defects filled with bioactive glass granules. The specific problem addressed was the limited understanding of how bioactive glass integrates with bone tissue compared to autogenous bone grafts. The motivation was to determine if bioactive glass could serve as a viable alternative to autogenous bone. The study focused on comparing bone regeneration outcomes between the two graft types. The researchers proposed that bioactive glass granules would support new bone formation without adverse effects. The study also aimed to assess the chemical interactions at the bone-graft interface. By using histomorphometry and scanning electron microscopy, the team sought to quantify bone growth and surface reactions. The goal was to provide evidence for the clinical potential of bioactive glass in orthopedic applications.

Cylindrical defects were created in the trochanter area of 18 rabbit femora. Half of the defects were filled with bioactive glass granules (600-830 microns in diameter). The other half received morcellized autogenous bone grafts. New bone formation was assessed using light microscopy and histomorphometry. Scanning electron microscopy was used to examine the surface reactions of the graft materials. Energy dispersive x-ray analysis (EDXA) was employed to study the chemical profile at the bone-graft interface. The study followed the rabbits for 3, 6, and 12 weeks to track bone regeneration. The thickness of the reaction layer on bioactive glass particles was measured over time. The absence of intervening soft tissue between bone lamellae and graft particles was a key observation.

After 3 weeks, 41% of bioactive glass-filled defects showed new bone formation. The corresponding figure for autogenous bone was 36%. By 6 weeks, bioactive glass had filled 32% of defects compared to 29% for autogenous bone. At 12 weeks, 38% of bioactive glass defects were filled versus 34% for autogenous bone. The reaction layer on bioactive glass particles thickened from 82 to 163 microns over time. EDXA revealed a chemical continuum between bioactive glass granules and new bone. No adverse reactions were observed in the bioactive glass group. The study found consistent direct contact between new bone lamellae and bioactive glass granules.

The authors propose that bioactive glass granules support new bone formation in cancellous defects. The study suggests that bioactive glass is as effective as autogenous bone grafts in promoting bone regeneration. The absence of adverse reactions supports the safety of bioactive glass in bone repair. The chemical continuity observed at the bone-graft interface may explain the integration of bioactive glass with new bone. The researchers suggest that bioactive glass granules could be a promising alternative to autogenous bone grafts. The study does not claim that bioactive glass is superior to autogenous bone but highlights its comparable performance. The findings may inform future studies on bioactive materials in orthopedic applications. The authors emphasize the need for further research to validate these results in clinical settings.